243 related articles for article (PubMed ID: 34277622)
1. Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m
Xu Y; He X; Deng J; Xiong L; Li Y; Zhang X; Chen W; Liu X; Xu X
Front Cell Dev Biol; 2021; 9():681745. PubMed ID: 34277622
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m
Yi L; Wu G; Guo L; Zou X; Huang P
Mol Ther Nucleic Acids; 2020 Sep; 21():299-314. PubMed ID: 32622331
[TBL] [Abstract][Full Text] [Related]
3. Genetic Alterations and Transcriptional Expression of m
Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
Front Oncol; 2020; 10():900. PubMed ID: 32850303
[No Abstract] [Full Text] [Related]
4. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer.
Xu Z; Chen Q; Shu L; Zhang C; Liu W; Wang P
Front Oncol; 2022; 12():970367. PubMed ID: 36003776
[TBL] [Abstract][Full Text] [Related]
5. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
6. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Cai J; Zhou M; Xu J
World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 and Immune Infiltration of m
Lin Y; Yao Y; Wang Y; Wang L; Cui H
Biomed Res Int; 2021; 2021():5516100. PubMed ID: 34055974
[TBL] [Abstract][Full Text] [Related]
10. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
[TBL] [Abstract][Full Text] [Related]
11. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
12. Immune Infiltrates of m
Feng ZY; Gao HY; Feng TD
Front Cell Dev Biol; 2021; 9():672248. PubMed ID: 34178999
[No Abstract] [Full Text] [Related]
13. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma.
Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J
Front Oncol; 2020; 10():1435. PubMed ID: 32974160
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
[No Abstract] [Full Text] [Related]
15. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
Shen S; Yan J; Zhang Y; Dong Z; Xing J; He Y
Ann Transl Med; 2021 Jan; 9(1):59. PubMed ID: 33553352
[TBL] [Abstract][Full Text] [Related]
16. m
Zhuang J; Lin C; Ye J
J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
[TBL] [Abstract][Full Text] [Related]
17. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
Front Oncol; 2021; 11():710767. PubMed ID: 34458149
[TBL] [Abstract][Full Text] [Related]
18. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
Kong F; Wang K; Wang L
Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
[TBL] [Abstract][Full Text] [Related]
20. Correlation of m6A methylation with immune infiltrates and poor prognosis in non-small cell lung cancer via a comprehensive analysis of RNA expression profiles.
Dong B; Wu C; Li SH; Huang L; Zhang C; Wu B; Sheng Y; Liu Y; Ye G; Qi Y
Ann Transl Med; 2021 Sep; 9(18):1465. PubMed ID: 34734017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
